Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | KCNQ3 | O43525 | 16/20 | 0.39 |
| ▸ | KCNQ2 | O43526 | 16/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1393374 | 0.94 | SMN1; SMN2 (0.41) | SMN1; SMN2ALDH1A1MAPTKCNQ3KCNQ2 | |
| Hydrochloric Acid SCHEMBL9757475 | 0.93 | SMN1; SMN2 (0.40) | SMN1; SMN2ALDH1A1MAPTKCNQ3KCNQ2 | |
| SCHEMBL8651643 | 0.87 | SMN1; SMN2 (0.40) | SMN1; SMN2ALDH1A1MAPTKCNQ3KCNQ2 | |
| SCHEMBL8662232 | 0.85 | SMN1; SMN2 (0.40) | SMN1; SMN2ALDH1A1MAPTKCNQ3KCNQ2 | |
| Hydrochloric Acid SCHEMBL9757484 | 0.84 | SMN1; SMN2 (0.39) | SMN1; SMN2ALDH1A1MAPTKCNQ3KCNQ2 | |
| Hydrochloric Acid SCHEMBL9757544 | 0.84 | SMN1; SMN2 (0.38) | SMN1; SMN2ALDH1A1MAPTKCNQ3KCNQ2 | |
| SCHEMBL9780233 | 0.83 | SMN1; SMN2 (0.46) | SMN1; SMN2ALDH1A1MAPTKCNQ3KCNQ2 | |
| SCHEMBL9471606 | 0.82 | KCNQ3 (0.43) | SMN1; SMN2ALDH1A1MAPTKCNQ3KCNQ2 | |
| SCHEMBL9471831 | 0.81 | SMN1; SMN2 (0.42) | SMN1; SMN2ALDH1A1MAPTKCNQ3KCNQ2 | |
| SCHEMBL9780326 | 0.81 | KCNQ3 (0.40) | SMN1; SMN2ALDH1A1MAPTKCNQ3KCNQ2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0863756-A1 | USE OF 2-IMINOBENZOTHIAZOLINES FOR TREATING PARKINSON'S DISEASE AND PARKINSONIAN SYNDROMES | Aventis Pharma S.A. (FR) | 1998-09-16 | — | — | EP | claimed |
| WO-1997020558-A1 | USE OF 2-IMINOBENZOTHIAZOLINES FOR TREATING PARKINSON'S DISEASE AND PARKINSONIAN SYNDROMES | RHONE-POULENC RORER S.A. (FR) | 1997-06-12 | — | — | WO | claimed |
| US-5240948-A | Anticonvulsants, nervous system disorders, conditions induced by glutamate | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1993-08-31 | — | — | US | claimed |
| US-5240948-A | Anticonvulsants, nervous system disorders, conditions induced by glutamate | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1993-08-31 | — | — | US | disclosed |